InnoHealth Group

Madrid, Spain Founded: 2014 • Age: 12 yrs Acquired By Evonik
Dermatological drugs are manufactured by InnoHealth Group in Spain.

About InnoHealth Group

InnoHealth Group is a Healthcare company based in Madrid (Spain) founded in 2014, and was acquired by Evonik in March 2020. Dermatological drugs are manufactured by InnoHealth Group in Spain. Its focus areas include Traditional Pharmaceuticals.

Company details

InnoHealth Group was established in 2014 and is headquartered in Madrid, Spain. Operations are focused on the pharmaceutical sector, where dermatological drugs are produced for medical applications. The company maintains its online presence through the domain innohealthgroup.com. Activities center on manufacturing processes tailored to skin-related treatments, with all principal functions based in the Spanish capital.

Key Metrics
  • Latest Funding Round
    $53.68K (USD), Grant

    Mar 2017

  • Investors
    Evonik

    & 2 more

  • Acquired by
    Evonik

    (Mar 2020)

Funding Insights of InnoHealth Group

  • Total Rounds 2
  • Last Round Grant β€” $53,678
  • First Round $53,305

    (Dec 2016)

  • Investors Count 2

All 2 funding rounds of InnoHealth Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2017$53,678Grant––
Dec 2016$53,305Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in InnoHealth Group

InnoHealth Group has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Evonik, European Union and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Evonik is recognized as a leader in specialty chemicals innovation.
1847evonik.comEssen, Germany
Premium access

Investor details for InnoHealth Group

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of InnoHealth Group

4 dated milestones of InnoHealth Group across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded InnoHealth Group is founded.
  2. Funding First funding round of $53K.
  3. Funding Latest funding round, Grant, of $54K.
  4. Exit Acquired by Evonik.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about InnoHealth Group

InnoHealth Group was founded in 2014 and raised its 1st funding round 2 years after it was founded.

InnoHealth Group is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.

InnoHealth Group was established in 2014 and is headquartered in Madrid, Spain. Operations are focused on the pharmaceutical sector, where dermatological drugs are produced for medical applications. The company maintains its online presence through the domain innohealthgroup.com. Activities center on manufacturing processes tailored to skin-related treatments, with all principal functions based in the Spanish capital.

InnoHealth Group has 3 investors. Key investors include Evonik, European Union, and EIC Fund.

Yes. InnoHealth Group was acquired by Evonik in March 2020.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available